Please login to the form below

Not currently logged in
Email:
Password:

pharma takeover

This page shows the latest pharma takeover news and features for those working in and with pharma, biotech and healthcare.

Mereo’s shareholders back OncoMed takeover

Deal expected to go through next week. UK company Mereo BioPharma is on the brink of a US listing, via the takeover of troubled US biotech OncoMed, after the deal was

Latest news

  • Sage raises $575m ahead of FDA review date for Zulresso Sage raises $575m ahead of FDA review date for Zulresso

    The company has been repeatedly mentioned in dispatches as a possible takeover target  by a big pharma group as its pipeline matures.

  • Pfizer takeover rumour ignites Amarin shares Pfizer takeover rumour ignites Amarin shares

    Shire acquisition and Bristol-Myers Squibb’s $74bn Celgene takeover, after failing to reach terms with AstraZeneca a few years ago. ... There are signs that M&A deal activity is picking up in pharma overall, particularly for large-scale transactions.

  • Takeda rebels take aim at Shire acquisition Takeda rebels take aim at Shire acquisition

    Shareholder group concerned about $30bn debt burden. Opposition to Takeda’s yet-to-be-finalised $63bn takeover of Shire appears to be building among some shareholders in Japan. ... of bolt-on acquisitions and licensing deals, including the $5.2bn

  • Vernalis accepts £33m takeover offer from Ligand Pharma Vernalis accepts £33m takeover offer from Ligand Pharma

    Biotech buyout brings team of 70 scientists in Cambridge, UK. After mulling over several takeover offers, UK biotech Vernalis has been won over by an overture from California’s Ligand Pharma ... Clinical-stage pipeline projects include Verona

  • Roche agrees $2.4bn takeover of genomics player Foundation Roche agrees $2.4bn takeover of genomics player Foundation

    Roche Pharma chief executive Daniel O’Day said taking over Foundation is an important part of its personalised healthcare strategy as “we believe molecular insights and the broad availability of high

More from news
Approximately 28 fully matching, plus 61 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2013 Pharma deals during July 2013

    July saw huge deal activity in the pharma industry, almost as if everyone was trying to close their deals before the holiday season. ... Elan's saga finally ends. We watched with great interest as Elan battled against the $6.7bn, increasing to $8bn,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Senior AstraZeneca exec jumps ship to small biotech Senior AstraZeneca exec jumps ship to small biotech

    He will leave the world's eight largest pharma firm to join a much smaller, privately owned biotech company, whose identity has not yet been publicly  revealed. ... 12 months ago the firm successfully rejected an $118bn takeover attempt from the US

  • Kite Pharma names Cynthia Butitta as CFO Kite Pharma names Cynthia Butitta as CFO

    She helped broker Pfizer’s takeover of NextWave Pharmaceuticals. Kite Pharma has named industry veteran Cynthia Butitta as chief financial officer. ... She was also VP of finance at the biotech Connetics. Kite Pharma is a biotech specialist in the

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics